Similar Articles
1141 Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence
1142 Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment
1143 Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma
1144 Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma
1145 Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients
1146 Growth inhibition and apoptosis induction by alternol in pancreatic carcinoma cells
1147 Three-dimensional morphometric analysis for hepatectomy of centrally located hepatocellular carcinoma: A pilot study
1148 Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: Propensity score analysis
1149 Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma
1150 Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA